1. |
[1]袁锦楣,李海峰格林-巴利综合征的最新进展[J].中国实用内科杂志2000;20:38-40.
|
2. |
[2]Hughes RA, van Der Meche FG. Corticosteroids for Guillain-Barresyndrome (Cochrane Review)[M/CD]. The Cochrane Library, Issue 1, 2002.
|
3. |
[3]Raphael JC, Chevret S, Hughes RA, et al. Plasma exchange for Guillain-Barre syndrome (Cochrane Review) [M/CD]. The Cochrane Library, Issue 1, 2002.
|
4. |
[4]Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome[J]. Lancet 1997; 349: 225-230.
|
5. |
[5]Wollinsky KH, Hulser PJ, Brinkmeier H, et al. CSF filtration is an effective treatment of Guillain-Barre syndrome: a randomized clinical trial[J]. Neurology 2001; 57: 774-780.
|
6. |
[6]Hughes RA, Raphael .JC, Swan AV, et al. Intravenous immunoglobulin for Guillain-Barre syndrome (Cochrane Review) [M/CD]. The Cochrane Library, Issue 1, 2002.
|
7. |
[7]Sharshar T, ChevretS, Bourdain F, et al. Early predictors of mechanical ventilation in Guillain-Barre syndrome[J]. Crit Care Med 2003;31: 278-283.
|
8. |
[8]Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barre syndrome[J]. Arch Neurol 2001; 58:893-898.
|
9. |
[9]Chevrolet JC, Deleamont P. Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barre syndrome[J]. Am Rev Respir Dis 1991;144:814-818.
|
10. |
[10]Wijdicks EFM, Borel CO. Respiratory management in acute neurologic illness[J]. Neurology 1998; 50: 11-20.
|
11. |
[11]Hughes RA. Management of acute neuromuscular paralysis[J]. J R Coll Physicians Lond 1998; 322: 254-259.
|
12. |
[12]Newton-John H. Prevention of pulmonary complications in severe Guillain-Barre syndrome by early assisted ventilation[J]. Med J Aust 1985; 142: 444-445.
|
13. |
[13]Fletcher DD, Lawn ND, Wolter TD, et al. Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation[J]. Neurology 2000; 54:2311-2315.
|
14. |
[14]Hughes RA. Systematic reviews of treatment for inflammatory demyelinating neuropathy[J]. JAnat 2002; 200:331-339.
|
15. |
[15]李海峰,丛志强Guillain-Barre综合征治疗进展[J].临床神经病学杂志2002;15:317-319.
|
16. |
[16]Esperou H, Jars-Guincestre MC, Bolgert F, et al. Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barre syndrome. French Cooperative Group on Plasma Exchange in GuillainBarre Syndrome[J]. Intensive Care Med 2000; 26: 1094-1100.
|